Literature DB >> 30328013

CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus.

Madina Mahesutihan1,2, Weinan Zheng1, Liang Cui1,2, Yun Li1, Pengtao Jiao3, Wenxian Yang1,2, Wei Liu4, Jing Li1, Wenhui Fan1, Limin Yang1, Wenjun Liu5,6, Lei Sun7,8.   

Abstract

Cyclophilin A (CypA) is a peptidyl-prolyl cis/trans isomerase that interacts with the matrix protein (M1) of influenza A virus (IAV) and restricts virus replication by regulating the ubiquitin-proteasome-mediated degradation of M1. However, the mechanism by which CypA regulates M1 ubiquitination remains unknown. In this study, we reported that E3 ubiquitin ligase AIP4 promoted K48-linked ubiquitination of M1 at K102 and K104, and accelerated ubiquitin-proteasome-mediated degradation of M1. The recombinant IAV with mutant M1 (K102R/K104R) could not be rescued, suggesting that the ubiquitination of M1 at K102/K104 was essential for IAV replication. Furthermore, CypA inhibited AIP4-mediated M1 ubiquitination by impairing the interaction between AIP4 and M1. More importantly, both the mutations of M1 (K102R/K104R) and CypA inhibited the nuclear export of M1, indicating that CypA regulates the cellular localization of M1 via inhibition of AIP4-mediated M1 ubiquitination at K102 and K104, which results in the reduced replication of IAV. Collectively, our findings reveal a novel ubiquitination-based mechanism by which CypA regulates the replication of IAV.

Entities:  

Keywords:  AIP4; Cyclophilin A (CypA); Influenza A virus (IAV); M1; Ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 30328013      PMCID: PMC6235765          DOI: 10.1007/s12250-018-0058-6

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  34 in total

1.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein.

Authors:  F Baudin; I Petit; W Weissenhorn; R W Ruigrok
Journal:  Virology       Date:  2001-03-01       Impact factor: 3.616

Review 3.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

5.  Structural organization of a filamentous influenza A virus.

Authors:  Lesley J Calder; Sebastian Wasilewski; John A Berriman; Peter B Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

6.  Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step.

Authors:  Ivy Widjaja; Erik de Vries; Donna M Tscherne; Adolfo García-Sastre; Peter J M Rottier; Cornelis A M de Haan
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

7.  Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication.

Authors:  Xiaoling Liu; Lei Sun; Maorong Yu; Zengfu Wang; Chongfeng Xu; Qinghua Xue; Ke Zhang; Xin Ye; Yoshihiro Kitamura; Wenjun Liu
Journal:  Cell Microbiol       Date:  2009-01-15       Impact factor: 3.715

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells.

Authors:  Rebecca Khor; Lisa J McElroy; Gary R Whittaker
Journal:  Traffic       Date:  2003-12       Impact factor: 6.215

10.  Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes.

Authors:  Laura M Burleigh; Lesley J Calder; John J Skehel; David A Steinhauer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

View more
  5 in total

Review 1.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

Review 2.  Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Authors:  Jinhe Han; Myoung Kyu Lee; Yejin Jang; Won-Jea Cho; Meeheyin Kim
Journal:  Drug Discov Today       Date:  2022-05-21       Impact factor: 8.369

3.  Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.

Authors:  Wenzhang Liang; Yue Zhang; Miao Li; Fadhl Al-Shaebi; Jian Li; Jing Zhang; Lin Wei
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 4.  Cyclophilin A: a key player for etiological agent infection.

Authors:  Yating Liao; Dan Luo; Kailan Peng; Yanhua Zeng
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-25       Impact factor: 5.560

5.  PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.

Authors:  Xianfeng Hui; Lei Cao; Ting Xu; Lianzhong Zhao; Kun Huang; Zhong Zou; Peilei Ren; Haiying Mao; Ying Yang; Shuo Gao; Xiaomei Sun; Xian Lin; Meilin Jin
Journal:  J Virol       Date:  2022-07-21       Impact factor: 6.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.